Cargando…
Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines
Waning immunity and emerging variants necessitate continued vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Improvements in vaccine safety, tolerability, and ease of manufacturing would benefit these efforts. Here, we develop a potent and easily manufactured nanopar...
Autores principales: | Dickey, Thayne H., Ma, Rui, Orr-Gonzalez, Sachy, Ouahes, Tarik, Patel, Palak, McAleese, Holly, Butler, Brandi, Eudy, Elizabeth, Eaton, Brett, Murphy, Michael, Kwan, Jennifer L., Salinas, Nichole D., Holbrook, Michael R., Lambert, Lynn E., Tolia, Niraj H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986124/ https://www.ncbi.nlm.nih.gov/pubmed/36943870 http://dx.doi.org/10.1016/j.celrep.2023.112266 |
Ejemplares similares
-
Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response
por: Dickey, Thayne H., et al.
Publicado: (2022) -
Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine
por: Dickey, Thayne H., et al.
Publicado: (2023) -
A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle
por: Salinas, Nichole D., et al.
Publicado: (2023) -
Structure-based design of a strain transcending AMA1-RON2L malaria vaccine
por: Patel, Palak N., et al.
Publicado: (2023) -
Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
por: Scaria, Puthupparampil V., et al.
Publicado: (2022)